{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:35:31Z","timestamp":1793500531287,"version":"4.5.0"},"reference-count":16,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,12,17]]},"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:p>Anti-interferon-gamma (IFN-\u03b3) autoantibodies has been recognised as an adult-onset immunodeficiency in the past decade in people who originate from Southeast Asia. These patients are susceptible to particular opportunistic infections, especially non-tuberculous mycobacteria (NTM). We present the case of a woman whom originally came from Thailand with disseminated <jats:italic>Mycobacterium avium<\/jats:italic> complex infection (pleural, pericardium, bloodstream and lung parenchymal involvement). Her infection continued to progress while receiving proper antibiotic treatment. Once high titre neutralising anti-IFN-\u03b3 autoantibodies were detected, rituximab was added as adjunctive treatment. The patient had remarkable clinical improvement against persistence of anti-IFN-\u03b3 autoantibodies. Although her lung disease has improved, the patient continues on triple therapy for NTM. The kinetics of anti-IFN-\u03b3 autoantibodies in the context of clinical progression, indication and length for rituximab and triple therapy is discussed in view of the current literature.<\/jats:p>","DOI":"10.1136\/bcr-2020-237909","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T13:03:00Z","timestamp":1611838980000},"page":"e237909","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Recurrent disseminated <i>Mycobacterium avium<\/i> in a female patient from Thailand with anti-interferon-gamma autoantibodies: dilemma on treatment approach"],"prefix":"10.1136","volume":"14","author":[{"given":"Kristen","family":"Zeitler","sequence":"first","affiliation":[{"name":"Pharmacy, Tampa General Hospital, Tampa, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolan","family":"Walter","sequence":"additional","affiliation":[{"name":"Pediatric Allergy\/Immunology, University of South Florida College of Medicine, Tampa, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Khan","sequence":"additional","affiliation":[{"name":"Pediatric Allergy\/Immunology, University of South Florida College of Medicine, Tampa, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chakrapol","family":"Sriaroon","sequence":"additional","affiliation":[{"name":"Pulmonary\/Critical Care, University of South Florida College of Medicine, Tampa, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,1,28]]},"reference":[{"key":"2025082701404311000_14.1.e237909.1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200604-571ST"},{"key":"2025082701404311000_14.1.e237909.2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176342","article-title":"Factors associated with acquired anti IFN- \u03b3 autoantibody in patients with nontuberculous mycobacterial infection","volume":"12","author":"Phoompoung","year":"2017","journal-title":"PLoS One"},{"key":"2025082701404311000_14.1.e237909.3","doi-asserted-by":"publisher","DOI":"10.3201\/eid2303.161708"},{"key":"2025082701404311000_14.1.e237909.4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151682","article-title":"High mortality of disseminated non-tuberculous mycobacterial infection in HIV-infected patients in the antiretroviral therapy era","volume":"11","author":"Kobayashi","year":"2016","journal-title":"PLoS One"},{"key":"2025082701404311000_14.1.e237909.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1111160"},{"key":"2025082701404311000_14.1.e237909.6","doi-asserted-by":"crossref","unstructured":"Hong GH , Ortega-Villa AM , Hunsberger S . Natural history and evolution of Anti-Interferon-\u03b3 autoantibody-associated immunodeficiency syndrome in Thailand and the US. Clin Infect Dis 2019:pii: ciz786.","DOI":"10.1093\/cid\/ciz786"},{"key":"2025082701404311000_14.1.e237909.7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215581","article-title":"Clinical outcome and laboratory markers for predicting disease activity in patients with disseminated opportunistic infections associated with anti-interferon-\u03b3 autoantibodies","volume":"14","author":"Angkasekwinai","year":"2019","journal-title":"PLoS One"},{"key":"2025082701404311000_14.1.e237909.8","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-017-0579-9"},{"key":"2025082701404311000_14.1.e237909.9","article-title":"Eosinophilic pneumonia and mycobacterial infection","volume":"193","author":"Hines","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2025082701404311000_14.1.e237909.10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-395707"},{"key":"2025082701404311000_14.1.e237909.11","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00089-4"},{"key":"2025082701404311000_14.1.e237909.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2006.07.010"},{"key":"2025082701404311000_14.1.e237909.13","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaci.2015.09.018","article-title":"Anti-IFN-\u03b3 autoantibodies are strongly associated with HLA-DR*15:02\/16:02 and HLA-DQ*05:01\/05:02 across Southeast Asia","volume":"137","author":"Ku","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2025082701404311000_14.1.e237909.14","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit809"},{"key":"2025082701404311000_14.1.e237909.15","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s10875-017-0425-3","article-title":"Rituximab restores IFN-\u03b3-STAT1 function and ameliorates disseminated Mycobacterium avium infection in a patient with Anti-Interferon-\u03b3 autoantibody","volume":"37","author":"Koizumi","year":"2017","journal-title":"J Clin Immunol"},{"key":"2025082701404311000_14.1.e237909.16","doi-asserted-by":"publisher","DOI":"10.1086\/605581"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-237909","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:40:52Z","timestamp":1756284052000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-237909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,28]]},"published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1136\/bcr-2020-237909"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-237909","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}